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Transitional hemodynamics in infants of diabetic mothers by targeted
neonatal echocardiography, electrocardiography and peripheral flow study
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ABSTRACT
Objective: Metabolic alterations of intrauterine environment in diabetes mellitus (DM) lead to
fetal cardiac dysfunctions that can persist after birth. The aim of the study was to assess the car-
diovascular adaptation in infants born to diabetic mothers (IDM) with different degrees of glyco-
metabolic control, in relation to revised guidelines for diagnosis of DM and quality
improvements in neonatal care.
Materials and methods: An observational case-control study was conducted on IDM with gesta-
tional, type 1 and type 2DM. Relevant maternal and neonatal anamnestic, clinical and laboratory
data were analyzed. Electrocardiographic and echocardiographic analyses, including structural
and systo-diastolic evaluation, were performed.
Results: In 68 IDM enrolled, we observed a lower incidence of negative perinatal outcome than
expected. Comparing to non-IDM, they presented larger fetal shunts, higher pulmonary pres-
sures, early and atrial wave velocities. At 72 hours, kinesis and heart rate variability remained
low. Cerebral blood flow velocities were higher. The most serious impairment of transition was
in pregestational IDM.
Conclusion: Maternal DM impaired neonatal transitional hemodynamics also in asymptomatic
IDM with good glycometabolic control. These results confirm the need for an early cardiologic
and cerebrovascular evaluation, to identify IDM with delayed maturation at risk of worse long-
term metabolic, cardiovascular, and neurodevelopmental outcome.
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Introduction
Maternal diabetes mellitus (DM) is the most frequent
endocrine complication in pregnancy together with
increased frequencies of type 2DM, obesity and meta-
bolic syndrome in reproductive age. In Italy, maternal
DM estimated prevalence is about 7% [1]. Despite the
improvements in obstetric surveillance, perinatal and
long-term adverse outcomes are still frequent [2].
Infants of diabetic mothers (IDM) are exposed to an
increased risk of structural cardiovascular abnormalities
due to multifactorial conditions caused by exposure
to prenatal hyperglycemia, alterations of the vascular
system and epigenetic mechanisms [3,4].
Furthermore, independently to structural altera-
tions, several studies in fetuses of mothers with
poor glycemic control confirm an altered cardiac
function [5]. Only few studies have evaluated the
postnatal cardiovascular adaptation in IDM with dif-
ferent degrees of maternal glycometabolic control.
Particularly, the risk of cardiac functional impairment
has not been thoroughly investigated in IDM with
good glycemic control, because these apparently
asymptomatic newborns often do not receive any
cardiac evaluation.
According to revised guidelines for the diagnosis of
DM in pregnancy and to the highest quality improve-
ment in neonatal care, the aim of the present study
was to assess the cardiac function in IDM, to identify
the infants at risk of short- and long-term adverse out-
comes requiring adequate follow-up.
Materials and methods
An observational case-control study was conducted at
the Department for Mother-Child Care, from March
2013 to February 2014, comparing IDM with a control-
group of non-IDM. Parental informed consent was
obtained.
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Study population
IDM with a diagnosis of gestational, type 1 or type
2DM, without chromosomal or complex anomalies,
were enrolled. Gestational DM (G-DM) is defined,
according to the guidelines for screening and diagnosis
of G-DM of the Italian National Institute of Health [6], as
a fasting plasma glucose level !5.1mmol/L or a posi-
tive 2-h 75-g-oral glucose tolerance test (OGTT) (plasma
glucose level !10mmol/L at 1 h, or !8.5mmol/L at
2 h), both in the absence of fasting plasma glucose level
!6.9mmol/L before the OGTT or before pregnancy.
The latter are diagnostic criterions for pregestational
DM (PG-DM). All IDM were matched for gender, gesta-
tional age and delivery mode, with a control group of
non-IDM without prenatal pathologies born in the
same period.
Study protocol
Relevant maternal and neonatal anamnestic, clinical
and laboratory data were collected. Maternal body
mass index (BMI) was defined as the body weight (kg)
divided by the square of the body height (m2); moth-
ers with a BMI !25 and <30 were classified as over-
weight and those with a BMI !30 as obese. A
maternal hemoglobin A1c (HbA1c) " 42mmol/mol
("6%) was considered as a normal value indicating
adequate glycometabolic control. Fetal growth and
amniotic fluid volume were annotated. According to
the Italian percentile charts [7], infants were classified
for birthweight in small, adequate, and large for gesta-
tional age (LGA). The ponderal index (PI), as a meas-
urement of nutritional status, was calculated as a
relationship between the body weight (kg) and the
cube of the body height (m3). Vital signs such as arte-
rial blood pressure, heart rate (HR) and pulse oximetry
were recorded. Laboratory determination of cord
blood insulin and C-peptide was performed. Capillary
blood glucose and hematocrit were evaluated within
2 h of life, to identify neonatal hypoglycemia (glucose
"2.5mmol/L) and polycythemia (hematocrit !70%).
Data regarding morbidity and days of hospitalization
were collected.
Echocardiographic examination
Serial-targeted neonatal echocardiographies (tnEcho),
including evaluation of systo-diastolic function, were
performed at 24, 48 and 72 h of life, using the Pro
Sound 5000 (Aloka, Tokyo, Japan, 5MHz transducer)
by two operators. The following measurements, aver-
aged offline from three cardiac cycles, were carried
out according to the recommendations of the
American Society of Echocardiography [8]: diastolic
dimensions of the left ventricle (LV), interventricular
septum (IVSd), LV posterior wall, cross-sectional valve
area (CSA), ejection fraction (EF) and shortening frac-
tion (FS) of LV in M-mode; ductus arteriosus (DA)
shunt, foramen ovale shunt and systolic pulmonary
artery pressure (PAPs) by continuous-wave Doppler;
mitral and tricuspid early (E) and atrial (A) wave veloc-
ities, E/A ratio, and cardiac index (CI¼ velocity time
integral$CSA$HR indexed to body surface area) by
pulsed-wave Doppler.
Tei-index was calculated as follows: Tei-index
¼ a%b/b¼ isovolumetric contraction timeþ isovolu-
metric relaxation time/ejection time. The right and LV
ejection times (interval “b”) were subtracted from the
interval from cessation to onset of tricuspid or mitral
valve inflow (interval “a”) to obtain the sum of isovolu-
metric contraction and relaxation times. The average
of 5 beats was reported to account for slight variations
in R–R cycle length.
Electrocardiogram analysis
One-minute standard 12-lead body surface electrocar-
diogram (ECG) was performed. QT (QTc) dispersion was
defined as the difference between the maximum and
minimum QT (QTc) intervals in the 12-leads. The ECG
was further analyzed for time-domain parameters of HR
variability (HRV) including: mean average of all normal
sinus RR intervals (NN intervals), standard deviation of
sinus RR intervals (SDNN), number of adjacent RR inter-
vals differing by more than 50ms, percentage of adja-
cent RR intervals differing by more than 50ms [9].
Cerebral and abdominal blood flow assessment
The cerebral and abdominal indexes of hemodynamic
adaptation were also analyzed. The anterior cerebral
artery was visualized in sagittal view through the ante-
rior fontanel using a 7MHz transducer. Measurements
of systolic peak, end-diastolic velocities and resistive
index were obtained. The maximal blood flow velocity
of the ductus venosus (DV) was measured at the inlet
of the portal vein by a sagittal subhepatic view.
Statistics
Statistical analysis was performed by open-source stat-
istical R Commander, and p value ".05 was considered
significant. Univariate analysis was conducted using
the chi-squared test for categorical variables and t-test,
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Wilcoxon test and Kruskal–Wallis test for continuous
variables [10].
Results
A total of 68 IDM were enrolled (42 males/26 females;
8 non-Caucasian), with institutional incidence of 10.3%
during the study period. Ten infants were born to
mothers with DM1, six to mothers with DM2 and 52 to
mothers with G-DM.
Diabetic mothers had an increased incidence of
pre-pregnancy comorbidities like thyroid diseases,
allergies or inflammatory bowel diseases (46 versus
24%; p¼ .008) and an increased pre-pregnancy BMI
(p¼ .0003), but did not develop preeclampsia. Twenty-
eight diabetic mothers were overweight and 11 obese,
compared to 17 and 5 non-diabetic mothers (p¼ .004
and p¼ .05, respectively). All diabetic mothers were on
hypocaloric diet. In addition, five (83%) mothers with
DM2 and 17 (33%) with G-DM were treated with insu-
lin. The stillbirth rate was 1.1%, no neonatal deaths
occurred. The perinatal and laboratory characteristics
of IDM and control group are shown in Table 1.
Eighteen IDM were LGA (p¼ .015); 11 (63%) of
these were born to mothers with G-DM. Neonatal PI
was significantly higher only in the subgroup of
infants born to mothers with DM1 (2.95 versus 2.68;
p¼ .02). The neonatal PI was directly correlated with
the maternal BMI (p¼ .09) and HbA1c (p¼ .006).
Congenital heart defects (CHD) were found in 4.6%
of non-IDM and 10.4% of IDM (p¼N.S.): in this latter
group five infants presented muscular IVS defects, one
a partial anomalous pulmonary venous return and one
a mild pulmonary stenosis. Other associated malforma-
tions were unilateral pyelectasis (2) and supernumerary
nipple (1).
The parameters of tnEcho of all IDM as well as the
subgroups PG-IDM and G-IDM versus control group
are reported in Table 2. The inter- and intraoperator
variability was <8%. Less than 3% missing data
occurred randomly and did not provide bias.
Hypertrophic IVSd was detected in 29.4% IDM (53% of
PG-IDM and 15% of G-IDM), 54% of these were born
to mothers with non-optimal glycometabolic control
(HbA1c >42mmol/mol) and 25% infants were also
LGA. IVSd was correlated directly to C-peptide
(p¼ .009) and HbA1c of III trimester (p¼ .006) but not
to LGA-rate.
At 48 h, IDM presented a higher left-to-right shunt
across the patent foramen ovale (45 versus 30%;
p¼ .05) and higher E and A-wave peak velocities com-
pared with controls. CI and Tei-index did not
significantly differ. At 72 h, EF and FS values remain
low compared to controls.
In IDM, the reduction of SDNN on ECG was corre-
lated with higher mother’s pre-pregnancy BMI
(p¼ .003) and lower Apgar scores at 10 and 50
(p¼ .0028 and p¼ .018, respectively). Additionally,
alterations in the electrical conduction system like the
presence of wandering atrial pacemaker were frequent
in IDM (20 versus 0%; p¼ .012). No differences were
detected for the HR or the other ECG parameters
(Table 3). However, the higher was HbA1c level in III
trimester, the deeper were S waves in V1 (p¼ .004)
and the higher was the Sokolow index (p¼ .01).
At 24 h of life, the cerebral and DV flow velocities
did not show group differences. At 48 and 72 h, IDM
presented hyperexcitability on specific neonatal neuro-
logic examination (p¼ .0002 for both), higher cerebral
peak systolic/end-diastolic velocities (40/17 versus
36/14 cm/s; p¼ .031 and 42/17 versus 37/14 cm/s;
p¼ .05) and lower DV velocities (36 versus 50 cm/s;
p¼ .05 and 38 versus 40 cm/s; p¼N.S.) than controls,
independently of blood pressure, hematocrit or LGA-rate.
Discussion
The high prevalence of DM in pregnancy that we
encountered agrees with data reported in literature,
where it varies between 5.2% and 32.5% in relation to
population characteristics (ethnic group, maternal age,
associated risk factors) and diagnostic guidelines [1].
The main differences were linked to the choice of uni-
versal or risk factor-based screening, to the execution
time of OGTT, and to the definition of the diagnostic
threshold values. In our study, a nationwide higher
rate of DM in pregnancy is probably related to the
presence in our institution of a diabetology service
and pregnancy diabetic reference center and low
OGTT cutoff. The Italian guidelines reserve the execu-
tion of the OGTT only to classes of risk, but use the
same cutoff values of International Association of
Diabetes and Pregnancy Study Groups [11]. The advan-
tage of these new guidelines to identify with more
accuracy the pregnant women at the risk of develop-
ing DM has been debated, particularly regarding the
concern for the medicalization of pregnancy, the treat-
ment costs and the limited evidence of benefits for
the treatment at lower diagnostic thresholds resulting
in overestimated diagnosis [12]. Lower cutoff might be
useful to identify also cases in which an exalted glu-
cose steal mechanism (high glucose flux from preg-
nant to fetus) could result in a false-negative OGTT.
Desoye and Nolan [13] hypothesized that this mechan-
ism can provide an explanation for mothers with
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normal OGTT who have offspring with evident charac-
teristics of diabetic fetopathy. However, due to lower
diagnostic thresholds and improved maternal manage-
ment, we observed a lower incidence of negative peri-
natal outcomes (e.g. birth trauma, perinatal asphyxia,
hypoglycemia, hyperbilirubinemia, respiratory or car-
diovascular failure) resulting in reduction of public-
health costs, although higher than in non-IDM.
Nevertheless, the alterations in fetal growth persist.
During intrauterine development, peptide hormones
such as insulin and insulin-like growth factors regulate
the normal fetal growth through a mitogenic function.
In IDM, the result of these mechanisms result altered
but an increase of cell proliferation does not necessar-
ily correspond to an increase in functional maturation
[14].
We reported a higher incidence of CHD compared
to that reported in the literature [15], not only in the
IDM group but also in the control group. This observa-
tion can be explained by the occasionally finding of
asymptomatic CHD just because infants were involved
in this study (e.g. small VSD closed spontaneously
early in life). We decided to not exclude these infants
because these minor CHD still do not have a hemo-
dynamic impact during the first days of life, when the
pulmonary resistance is still high, and occurred in
both groups equally. Moreover, maternal overweight
or unrecognized alterations of glucose metabolism
before pregnancy could have contributed to this
increased incidence in both groups. Hyperglycemia,
altered lipid metabolism and non-enzymatic glycosyla-
tion of proteins are responsible of increased oxidative
stress and activation of apoptotic cascade, resulting in
adverse effects on embryogenesis [3,4,16]. These
mechanisms can alter the neural crest cell migration
involved in cardiac structural development [17].
Table 2. Median echocardiographic data.
p values
Non-IDM
(n¼ 68)
IDM
(n¼ 68)
PG-IDM
(n¼ 16)
G-IDM
(n¼ 52)
IDM versus
non-IDM
PG-IDM versus
non-IDM
G-IDM versus
non-IDM
Cardiac morphometry
IVSd, cm 0.39 0.44 0.50 0.42 <.001 <.001 .035
LVPW, cm 0.26 0.27 0.27 0.25 .417 .325 .602
Diastolic functionality
Mitral E wave 48 h, m/s 0.54 0.6 0.61 0.60 .160 .507 .160
Mitral A wave 48 h, m/s 0.51 0.56 0.55 0.56 .005 .015 .024
Mitral E/A wave 48 h 1.09 1.05 1.05 1.05 .124 .135 .241
Tricuspid E wave 48 h, m/s 0.43 0.5 0.51 0.48 .005 .050 .012
Tricuspid A wave 48 h, m/s 0.56 0.6 0.61 0.60 .007 .090 .013
Tricuspid E/A wave 48 h 0.78 0.79 0.77 0.80 .281 .593 .285
Systolic functionality
PAPs 24 h, mmHg 12 10.6 18.8 9.85 .699 .068 .150
PAPs 48 h, mmHg 12 12.5 16 12 .914 .409 .811
Right CI 48 h, L/min/m2 4.54 4.42 5.75 4.15 .762 .127 .273
Left CI 48 h, L/min/m2 3.83 3.71 3.63 3.80 .378 .526 .438
EF 48 h, % 52.2 52.9 53 51.8 .821 .673 .636
EF 72 h, % 62.7 49.9 53.9 47.8 .050 .216 .065
FS 48 h, % 24.9 23.7 21.8 23.8 .882 .610 .957
FS 72 h, % 30.9 22.1 25.6 21.4 .044 .208 .050
Systo-diastolic functionality
Right Tei index 48 h 0.24 0.22 0.18 0.25 .978 .224 .611
Right Tei index 72 h 0.2 0.27 0.26 0.30 .234 .610 .211
Left Tei index 48 h 0.3 0.31 0.32 0.31 .452 .303 .653
Left Tei index 72 h 0.31 0.26 0.31 0.26 .693 .649 .403
IDM: infants of diabetic mothers; PG: pregestational diabetes; G: gestational diabetes; IVSd: interventricular septum; LVPW: left ventricular posterior wall;
E: early wave; A: atrial wave; PAPs: pulmonary artery pressure; CI: cardiac index; EF: ejection fraction; FS: shortening fraction. Significant differences are in
bold type.
Table 3. Median electrocardiographic data.
p values
Non-IDM
(n¼ 68) IDM (n¼ 68)
PG-IDM
(n¼ 16)
G-IDM
(n¼ 52)
IDM versus
non-IDM
PG-IDM versus
non-IDM
G-IDM versus
non-IDM
RR mean, ms 486 480 455 487 .418 .098 .833
SDNN, ms 25.8 21.2 19.8 22.7 .025 .225 .029
QTc, ms 437 440 455 439 .919 .652 .738
QTc dispersion, ms 95 85 67 86 .245 .068 .579
Amplitude R/S V2 1.25 1.21 0.92 1.25 .835 .223 .754
Sokolow index 2.73 2.82 3.28 2.59 .587 .093 .905
T-wave negativity 3 3 2 3 .037 .019 .141
IDM: infants of diabetic mothers; PG: pregestational diabetes; G: gestational diabetes; SDNN: standard deviation of normal sinus R–R intervals. Significant
differences are in bold type.
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In this study, a high incidence of myocardial hyper-
trophy was also confirmed, especially in PG-IDM.
The persistence of elevated HbA1c throughout the
pregnancy has been linked with the most marked sep-
tal hypertrophy due to stabilization of above-men-
tioned structural changes. However, these structural
alterations tend to regress in the early months of life
and did not cause a clinically significant obstructive
pattern in our population.
Several studies have proved abnormal maturation
of cardiac functionality in the fetal age linked to struc-
tural alterations [18,19]. In the neonatal period, few
data are available for cardiac functionality, probably
because IDM with a good hemodynamic compensation
are not subjected to routine tnEcho. Two American
studies, conducted on small sample size (12 PG-IDM/
20G-IDM and 0 PG-IDM/22G-IDM, respectively), have
demonstrated a compromised transitional period
(increased PAPs and right-to-left shunt across DA,
reduction of the FS and right CI), without any clinical
signs of cardiovascular failure [20,21]. Our study can
partially confirm these data. At 24 h of life, no signifi-
cant differences between IDM and non-IDM groups
were observed, probably because the early transitional
period concerns all newborns in the same way. In the
following hours, we observed persistent larger fetal
shunts without any improvement of systolic kinesis
(persistent low FS and EF) in IDM compared to non-
IDM. Furthermore, higher velocities in mitral and tri-
cuspid A and E waves in IDM suggest an impairment
of diastolic ventricular relaxation and compliance,
related to LV stiffness and myocardial hypertrophy.
Other tnEcho data involved in the global systo-dia-
stolic dysfunction, including the Tei-index, did not
show significant differences probably because of a bet-
ter overall outcome of IDM.
Comparing the sub-groups of IDM, we observed dif-
ferences in cardiovascular adaption, because DM in
pregnancy is not a homogeneous pathophysiologic
process. According to the literature data, we confirmed
a slower cardiovascular adaptation especially in PG-
IDM, who presented slightly higher PAPs in the first
days. Poor glycemic control early in pregnancy results
in an establishment of fetal hyperinsulinemia and fetal
glucose steal mechanism with persistent fetal hyper-
glycemia and oxidative stress, which in turn is respon-
sible for vascular smooth muscle growth and
inflammation promoting pulmonary hypertension
[13,16]. However, prolonged exposure to hypergly-
cemia during pregnancy can only partly explain the
increase of cardiovascular impairment. As reported by
Chu et al. [5], even a good maternal glycometabolic
control can only delay the onset of cardiac damage,
but cannot avoid it completely. Indeed, also in G-IDM,
exposed to hyperglycemia late in pregnancy, we
observed an altered systolic function likely due to fre-
quently associated maternal comorbidities, like over-
weight and obesity, which act as independent
metabolic risk factors.
At the level of peripheral vascular district, a detec-
tion of abnormal flow in the DV might be due to alter-
ation in cardiac diastolic functionality as described
previously in fetal age [18]. However, not even in IDM
with severe IVSd hypertrophy or high PAPs, we found
reverse flow pattern in DV, confirming that these new-
borns did not reach supra-systemic pulmonary hyper-
tension [22]. In addition, the abnormal cerebral blood
flow velocity underlines hemodynamic alterations. The
increase of peak systolic and end-diastolic flow veloc-
ities in IDM is probably related to increased cerebral
blood flow by persistence of fetal shunts and cerebral
sparing mechanism.
The analysis of postnatal cardiovascular immaturity
can be supplemented by the ECG data. A significant
association detected between a deep S wave in V1
and the septal thickness in IDM confirms the hypoth-
esis that the amplitude of the QRS is probably related
to changes in cellular metabolic activity, regardless of
myocardial hypertrophy. Calabr!o et al. [23] have also
observed an alteration of the QRS with deep S waves
in V1-V2, even in the absence of LV hypertrophy.
Moreover, literature data reported signs of immaturity
of the conduction system, like wandering atrial pace-
maker or arrhythmias associated with diastolic dys-
function [24], and an increase of QT dispersion,
particularly in children with cardiac hypertrophy [25].
Inexplicably, we did not find the latter sign of elec-
trical instability of the myocardium, responsible of
abnormal conduction.
The study has evidenced a lower HRV in IDM,
expressed as a reduction of SDNN. Previously, this pa-
rameter has been used as an indicator of autonomic
dysfunction with poor prognosis in sudden death or
growth restriction [26], and in infants born to mothers
with type 1DM [27]. In the control group HRV
increases with gestational age, namely with the matu-
ration of the autonomic nervous system, in IDM this
gestational age correlation was not observed. It can be
assumed that the data on HRV can represent an early
indicator of altered cellular metabolic activity, related
to mechanisms not yet completely clarified.
All these described functional changes are pro-
gramed at the beginning of pregnancy, probably by
the action of glycosylation processes on cell fate and
functional maturation. These altered fetal programing
induced by metabolic imbalance and (epi-)genetic
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changes can persist during the neonatal cardiovascular
adaptation and can result in an increased cardiovascu-
lar risk also later in life [28]. A European study of heart
function at school-age showed no abnormalities in
infants of mothers with type 1DM, but this study group
was composed by only 30 children almost all without
myocardial hypertrophy in neonatal age [29]. Instead,
an Australian study reported a pro-
atherosclerotic hyperlipidemic state with vascular
inflammation and endothelial dysfunction in IDM at
pediatric age. Long-term follow-up in a larger cohort of
IDM with neonatal septal hypertrophy, such as found in
our study, could prove a significant increase of cardio-
vascular risk [30]. The limitation of this study is the
small size of the three IDM subgroups. Particularly, the
small number of IDM from type 2DM mothers (only 6)
implies low statistical power.
Conclusions
Despite improved multidisciplinary management of
diabetic pregnancy and inclusion of prevalent asymp-
tomatic IDM in our study, we detected impaired
neonatal transitional hemodynamics linked to cardio-
vascular and cerebrovascular immaturity.
In addition to the clinical and biochemical monitor-
ing, a complete cardiac and cerebral evaluation within
48–72 h of life seems appropriate to search these
hemodynamic alterations, even in clinically silent IDM.
The observed different short-term outcome in sub-
groups of IDM justifies a multicenter clinical trial
including a representative population of all types of
maternal DM with variable degrees of metabolic con-
trol, to identify delays of maturation, to establish opti-
mal guidelines cutoff, and to perform an adequate
long-term follow-up.
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